BusinessCrown Bioscience and Data Sciences International (DSI) Partner to Advance Metabolic Disease Research Using an Implanted Telemetry Device for Long-Term Blood Glucose MonitoringBy Nasdaq OMXNov 23, 2017, 1:00 PM UTC
BusinessCrownBio’s Translatable FATZO Model Utilized in Eli Lilly’s Preclinical Type 2 Diabetes Research ProgramsBy Nasdaq OMXNov 21, 2017, 1:00 PM UTC
BusinessCrownBio Enhances Its European Capabilities with New Generation of Innovative Translational Models for Obesity and DiabetesBy Nasdaq OMXOct 10, 2017, 1:32 PM UTC
BusinessCrown Bioscience Names Laurie Heilmann Chief Business Officer; Executive Leader Brings Expertise in Global Strategy and Commercial Leadership to the RoleBy Nasdaq OMXSep 27, 2017, 12:01 PM UTC
